Stockscreener 앱 받기
1.215
1.68%
0.025
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
Transcript : Lucid Diagnostics Inc., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com
Earnings call transcript: Lucid Diagnostics Q1 2025 highlights growth and strategic expansion - Investing.com Australia
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Lucid Diagnostics Reports Q1 2025 Financial Results - TipRanks
Lucid Diagnostics reports Q1 adjusted EPS (16c), consensus (10c) - TipRanks
Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results - PR Newswire
Lucid Diagnostics Inc. SEC 10-Q Report - TradingView
Lucid Diagnostics (LUCD) Expected to Announce Earnings on Wednesday - Defense World
Financial Analysis: Lucid Diagnostics Inc (LUCD)’s Ratios Unveil Key Insights - DWinneX
Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Lucid Diagnostics Inc. (NASDAQ:LUCD) Shares Bought by Geode Capital Management LLC - Defense World
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Kilgore News Herald
LPL Financial LLC Raises Stock Holdings in Lucid Diagnostics Inc. (NASDAQ:LUCD) - Defense World
PAVmed Sets Key Q1 2025 Earnings Call: MedTech Growth Strategy and Financial Results Coming May 15 - Stock Titan
Lucid reports encouraging results from EsoGuard study - MSN
Lucid Diagnostics (LUCD) Showcases Promising Data for EsoGuard T - GuruFocus
A look into Lucid Diagnostics Inc (LUCD)’s deeper side - Sete News
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD - BioSpace
PAVmed, Lucid post encouraging results from EsoGuard study (LUCD:NASDAQ) - Seeking Alpha
Lucid Reports Positive Data For EsoGuard Esophageal DNA Test In Patients Without Symptomatic GERD - Nasdaq
Lucid DiagnosticsNarrowing Losses, Expanding Opportunities In Esophageal Cancer Care - RTTNews
Did Lucid Diagnostics Inc (LUCD) perform well in the last session? - uspostnews.com
Ascendiant Capital Markets Forecasts Strong Price Appreciation for Lucid Diagnostics (NASDAQ:LUCD) Stock - The AM Reporter
Lucid Diagnostics (NASDAQ:LUCD) Price Target Raised to $7.50 at Ascendiant Capital Markets - Defense World
Stock Performance Spotlight: Lucid Diagnostics Inc (LUCD) Ends the Day at 1.21, Up by 11.01 - DWinneX
Lucid Diagnostics (LUCD) Sees Price Target Increase Amid Growth Potential | LUCD Stock News - GuruFocus
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume - ADVFN
PAVmed Provides Business Update and Second Quarter 2024 Financial Results - ADVFN
Lucid Diagnostics finalizes public offering of common stock - Medical Buyer
Lucid Diagnostics’ (LUCD) Buy Rating Reiterated at Needham & Company LLC - Defense World
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - The Bradford Era
Lucid Diagnostics Closes $16.1 Million Public Offering - MSN
Lucid Diagnostics completes $16.1 million stock offering By Investing.com - Investing.com South Africa
Lucid Diagnostics Raises $16.1 Mln Through Public Offering To Support Corporate Growth - Nasdaq
Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN
Lucid Diagnostics Inc (LUCD) With A Potential Upside Of More Than -100.0% - stocksregister.com
Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst - Benzinga
Lucid Diagnostics Announces Closing of Public Offering of Common Stock - GuruFocus
Lucid Diagnostics completes $16.1 million stock offering - Investing.com Australia
Lucid Diagnostics Announces Closing Of Public Offering Of Common Stock - marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Lucid Diagnostics Shares Fall After Pricing Stock Offering - marketscreener.com
Lucid Diagnostics Announces Public Stock Offering - TipRanks
Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway - MSN
Lucid Diagnostics Announces Proposed Public Offering of Common Stock - The Malaysian Reserve
Lucid Diagnostics announces proposed public offering of common stock - MSN
Lucid Diagnostics Announces Pricing Of Public Offering Of Common Stock - MarketScreener
2.03%
2.15%
자본화:
|
볼륨(24시간):